Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Ocul Surf. 2020 Jun 3;19:183–189. doi: 10.1016/j.jtos.2020.05.012

Table 3.

Clinical findings in different levels of dry eye disease (DED) clinical severity based on Dry Eye Workshop (DEWS) classification.

DEWS Clinical Severity in DED Group
Level 1(n = 97) Level 2(n = 106) Level 3(n = 65) Level 4(n = 26) p (GLM)
Conjunctival Injection 0.48 ± 0.09 0.42 ± 0.10 0.52 ± 0.11 1.03 ± 0.06* 0.007
Lissamine Conjunctival Staining 0.96 ± 0.18 1.19 ± 0.18 1.58 ± 0.16* 1.36 ± 0.10* 0.021
Fluorescein Corneal Staining 0.83 ± 0.11 1.29 ± 0.10* 1.85 ± 0.14* 2.04 ± 0.07* < 0.001
Tear BreakUp Time (TBUT) (seconds) 6.90 ± 0.27 4.68 ± 0.20* 2.99 ± 0.25* 2.40 ± 0.16* < 0.001
Schirmer’s Score(mm) 14.89 ± 0.48 11.13 ± 0.55* 6.05 ± 0.57* 1.24 ± 0.39* < 0.001
OSDI 38.77 ± 5.39 50.43 ± 5.18 39.01 ± 5.20 49.61 ± 2.93 0.293

Data presented as mean ± standard deviation.

*

p < 0.05 compared to level 1;

p < 0.05 compared to level 2;

p < 0.05 compared to level 3 assessed by GLM.